Search Within

Craig Moskowitz

Formats
  1. Meeting Abstract (229)
  2. Journal Article (174)
  3. Book Section (3)
  4. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Hematologic Malignancies, Division of (407)
  3. Center for Hematologic Malignancies (288)
  4. Lymphoma (273)
  5. Survivorship Research (176)
  6. Epidemiology and Biostatistics (103)

More Groups

People
  1. Andrew Zelenetz (207)
  2. David Straus (117)
  3. Paul Hamlin (113)
  4. Carol Portlock (106)
  5. Ariela Noy (94)
  6. Matthew Matasar (91)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (6)
  6. 2019 (8)

More Years

Publications
  1. Blood (160)
  2. Journal of Clinical Oncology (46)
  3. Biology of Blood and Marrow Transplantation (23)
  4. Annals of Oncology (17)
  5. British Journal of Haematology (17)
  6. Haematologica (16)

More Publications

Publishers
  1. American Society of Hematology (165)
  2. American Society of Clinical Oncology (46)
  3. Elsevier Inc. (44)
  4. Oxford University Press (20)
  5. John Wiley & Sons (18)
  6. Ferrata Storti Foundation (16)

More Publishers

Results (407)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma (DLBCL) patients failing second-line R-DHAP or R-ICE chemotherapy included in the CORAL study
    Meeting Abstract

    Van Den Neste, E.; Gisselbrecht, C.; Schmitz, N.; Mounier, N.; Gill, D. S.; Linch, D.; Trneny, M.; Milpied, N.; Radford, J.; Ketterer, N.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Excellent outcomes for limited-stage diffuse large B-cell lymphoma in the rituximab era: A retrospective analysis from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Kumar, A.; Maragulia, J. C.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A. D.
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Autologous stem cell transplant is a feasible treatment for older relapsed and refractory Hodgkin lymphoma patients
    Meeting Abstract

    Glick, H.; Lee, C.; Sauter, C. S.; Moskowitz, C. H.; Matasar, M. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Impact of renal insufficiency and obesity on safety and outcomes of BEAM conditioning
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Zhang, Z.; Shi, W.; Moskowitz, C. H.; Matasar, M. J.
    Blood (2013)

    Fulltext@MSK | Save
  • Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred?
    Meeting Abstract

    Omuro, A.; Abrey, L.; Raizer, J.; Paleologos, N.; Forsyth, P.; DeAngelis, L.; Kaley, T.; Louis, D.; Cairncross, J. G.; Matasar, M.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission
    Journal Article

    Mehta, N.; Maragulia, J. C.; Moskowitz, A.; Hamlin, P. A.; Lunning, M. A.; Moskowitz, C. H.; Zelenetz, A.; Matasar, M. J.; Sauter, C.; Goldberg, J.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2013)

    Fulltext@MSK | Save
  • Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma
    Journal Article

    Matasar, M. J.; Czuczman, M. S.; Rodriguez, M. A.; Fennessy, M.; Shea, T. C.; Spitzer, G.; Lossos, I. S.; Kharfan-Dabaja, M. A.; Joyce, R.; Fayad, L.; more...
    Blood (2013)

    Fulltext@MSK | Save